Used as an active pharmaceutical ingredient in the development of drugs targeting type 2 diabetes. It functions as a selective agonist for the GPR40 receptor, which plays a key role in glucose-dependent insulin secretion. This mechanism enhances insulin release only when blood glucose levels are elevated, reducing the risk of hypoglycemia. Its application is primarily in clinical research and therapeutic strategies aimed at improving glycemic control in diabetic patients.